Patent · US Active

Formulations for small intestinal delivery of RSV and norovirus antigens

US12186407B2 · kind B2 · utility

0Cited by
8References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 2, 2022
Grant dateJan 7, 2025
Priority date
Expiry dateAug 2, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/16034
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compositions and methods for generating an immunogenic response in humans. Further provided are methods for designing such compositions, e.g., for vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.